A hepatocyte-derived GPNMB–RYK signaling axis in MASH progression

JHEP Reports · Published 2026-07-01 · DOI 10.1016/j.jhepr.2026.101889

Authors (2)

Yuanyuan Fan, Cynthia Ju

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Citation

Fan, Y., Ju, C. (2026). A hepatocyte-derived GPNMB–RYK signaling axis in MASH progression. JHEP Reports. https://doi.org/10.1016/j.jhepr.2026.101889

Related articles

Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort · JHEP Reports · 2026 · Same journal
Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice · JHEP Reports · 2026 · Same journal
Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS) · JHEP Reports · 2026 · Same journal
Global Trends in National Alcohol Control Policies Between 2010–2019 · JHEP Reports · 2026 · Same journal
Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury? · JHEP Reports · 2026 · Same journal
Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up Study · JHEP Reports · 2026 · Same journal
The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆ · JHEP Reports · 2026 · Same journal
Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B · JHEP Reports · 2026 · Same journal
Changes in alcohol use following a diagnosis of alcohol-related liver disease: a clinical cohort study · JHEP Reports · 2026 · Same journal
Corticosteroids in severe alcohol-related hepatitis: a multicenter randomized clinical trial · JHEP Reports · 2026 · Same journal